Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of PRS-080 in Healthy Volunteers
NCT02340572Phase 1Completed
- Sponsor
- Pieris Pharmaceuticals
- Start
- Nov 2014
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in anemia of chronic disease (ACD) comparing PRS-080 with Placebo (2 arms). Primary endpoint: Number of subjects with adverse events up to 28 days. Started Nov 2014; status: completed.
02
Drugs
PRS-080
03
Conditions
anemia of chronic disease (ACD)
Beyond the preview
Go deeper on NCT02340572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02340572.